Drug
Qutenza
Qutenza: highest development phase Phase 2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Qutenza (8% capsaicin) NCT01260454 | Phase 2 | Pulmonary Hypertension |
Latest
No recent events.
Follow Qutenza on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.